this post was submitted on 08 May 2025
17 points (100.0% liked)

Futurology

3110 readers
59 users here now

founded 2 years ago
MODERATORS
voidx@futurology.today
Lugh@futurology.today
Espiritdescali@futurology.today
AwesomeLowlander@futurology.today
17
First-in-human clinical trial testing CRISPR/Cas9 gene-editing in 12 highly metastatic, end-stage GI cancer patients saw several of their cancer growth halt & not return over 2 year period. (med.umn.edu)
submitted 3 months ago by Lugh@futurology.today to c/futurology@futurology.today
1 comments fedilink hide all child comments
top 1 comments
sorted by: hot top controversial new old
[–] manxu@piefed.social 2 points 3 months ago

I have seen enough loved ones affected by GI cancer, the only bad thing about this news is that it didn't come ten years ago!